Edwards Lifesciences C
COM · CUSIP 26176E108
1
institutional holders
21.8k
shares reported held*
$2.1mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $94.34.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 1 |
| Q4 2022 | 0 |
| Q1 2023 | 0 |
| Q2 2023 | 1 |
Biggest buyers
| AlphaMark Advisors, LLC | New | +21.8k |
Biggest sellers
| None |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| AlphaMark Advisors, LLC 0.95% of their portfolio | 21.8k $2.1m | New |